Who Qualifies for Spravato Treatment? Signs You May Be a Good Candidate

Am I a Good Candidate for Spravato Treatment?

If you have been living with depression for months or even years, you may have asked yourself a difficult question: "Why am I still not getting better?"

Perhaps you have tried one antidepressant after another. Maybe you have adjusted doses, switched medications, attended counseling, exercised more, improved your sleep, or made healthy lifestyle changes. While these treatments help many people, they do not work for everyone.

If your depression continues despite treatment, you may have heard about Spravato and wondered whether it could be an option for you.

One of the most common questions patients ask is:

Who qualifies for Spravato treatment?

The answer is not always straightforward because every person's medical history, symptoms, and treatment journey are different. Eligibility depends on several clinical factors, and a thorough psychiatric evaluation is essential before determining whether Spravato is appropriate.

In this guide, we'll explain who may qualify for Spravato treatment, how providers determine candidacy, what conditions Spravato is approved to treat, and what you can expect if you are considering treatment at Affective Mental Wellness in New Braunfels, Texas.

What Is Spravato?

Spravato is the brand name for esketamine, a prescription nasal spray that is approved by the United States Food and Drug Administration for certain adults with depression.

Unlike traditional antidepressants that primarily affect serotonin, norepinephrine, or dopamine, Spravato works through the brain's glutamate system. Glutamate is the brain's most abundant excitatory neurotransmitter and plays an important role in learning, memory, communication between nerve cells, and neuroplasticity.

Neuroplasticity refers to the brain's ability to adapt, reorganize, and form new neural connections. Researchers believe this may be one reason Spravato can benefit some individuals whose depression has not improved with conventional antidepressants.

Because of its unique mechanism and safety requirements, Spravato is only administered in certified medical clinics under the supervision of trained healthcare providers.

Who Qualifies for Spravato Treatment?

The primary keyword many people search is who qualifies for Spravato treatment, but eligibility involves more than simply having depression.

Generally, Spravato is considered for adults who meet specific clinical criteria.

You may qualify if:

• You are an adult diagnosed with major depressive disorder.

• Your depression has not adequately improved after trying at least two antidepressant medications.

• Your provider determines that your symptoms meet the criteria for treatment resistant depression.

• You are medically appropriate for treatment after a comprehensive psychiatric evaluation.

• You are able to attend in clinic appointments for treatment and observation.

Meeting these criteria does not automatically mean Spravato is the right choice, but it often means it is worth discussing with a qualified psychiatric provider.

What Is Treatment Resistant Depression?

One of the biggest factors in determining eligibility is whether you have treatment resistant depression.

Treatment resistant depression generally refers to depression that has not improved after trying at least two different antidepressant medications at appropriate doses and for an adequate period of time.

This does not mean your depression is untreatable.

Instead, it simply means that traditional first line treatments have not provided enough relief.

Many people incorrectly assume they are "out of options" after several medications fail. Fortunately, advances in psychiatric care have created additional treatment possibilities, including Spravato.

Signs You May Have Treatment Resistant Depression

While only a qualified provider can diagnose treatment resistant depression, some common signs include:

• Your symptoms have persisted despite treatment.

• You have tried multiple antidepressants without meaningful improvement.

• You continue struggling with low mood most days.

• Daily responsibilities feel increasingly difficult.

• You have lost interest in activities you once enjoyed.

• Depression continues affecting relationships or work.

• Your provider has repeatedly adjusted medications with little success.

If this sounds familiar, discussing advanced treatment options with a psychiatric provider may be appropriate.

Conditions Spravato Is Approved to Treat

Spravato is currently approved for adults with:

• Major depressive disorder with treatment resistant depression.

• Certain adults with major depressive disorder experiencing acute suicidal thoughts or behaviors when used as part of a comprehensive treatment plan.

Your psychiatric provider will determine whether your diagnosis aligns with current treatment guidelines.

Why a Psychiatric Evaluation Is So Important

One of the biggest misconceptions about Spravato is that anyone with depression can receive it immediately.

In reality, the evaluation process is one of the most important parts of treatment.

During your psychiatric evaluation, your provider may discuss:

• Your current symptoms.

• Previous medication history.

• Past therapy experiences.

• Medical conditions.

• Family mental health history.

• Current medications and supplements.

• Safety considerations.

• Treatment goals.

This comprehensive evaluation helps determine whether Spravato is appropriate or whether another treatment may better fit your needs.

Questions Your Provider May Ask

To better understand your depression, your provider may ask questions such as:

• How long have you experienced symptoms?

• What medications have you tried?

• Did any medications provide partial improvement?

• Have you experienced significant side effects?

• Have you participated in counseling?

• How are your sleep and appetite?

• Have your symptoms affected work or relationships?

• Do you have anxiety or other mental health conditions?

These questions allow your provider to develop an individualized treatment plan rather than relying on a one size fits all approach.

Who May Not Be a Good Candidate for Spravato?

While Spravato has helped many people, it is not appropriate for everyone.

Depending on your medical history, your provider may recommend another treatment approach.

Certain medical conditions or safety concerns may require additional evaluation before proceeding.

This is another reason why individualized psychiatric care is so important.

Why Spravato Is Given in a Medical Clinic

Unlike traditional antidepressants, Spravato cannot be taken at home.

Every treatment takes place in a certified healthcare setting because patients require monitoring afterward.

This monitoring helps providers observe for temporary side effects such as:

• Drowsiness

• Dizziness

• Dissociation

• Nausea

• Temporary increases in blood pressure

These effects generally improve as the medication wears off, but monitoring is an important part of safe treatment.

What Does the Spravato Treatment Process Look Like?

If you qualify, treatment generally follows several steps.

Initial Evaluation

Your psychiatric provider reviews your history and determines whether Spravato is appropriate.

Insurance Verification

If applicable, your treatment team works with your insurance company regarding prior authorization and benefits.

Treatment Sessions

Spravato is administered as a nasal spray in the clinic.

Observation Period

Patients remain under observation for approximately two hours after treatment.

Ongoing Follow Up

Your provider monitors your progress and adjusts your treatment plan as needed.

How Long Does Spravato Treatment Last?

Treatment schedules vary depending on individual needs.

Many patients begin with more frequent visits before transitioning to maintenance treatments.

Your provider will determine an appropriate schedule based on your response.

Can Spravato Be Combined With Other Treatments?

Yes.

Spravato is often used as one component of a broader treatment plan.

Depending on your needs, this may include:

• Medication management

• Psychotherapy

• Lifestyle interventions

• Sleep optimization

• Stress management

• Follow up psychiatric care

Combining evidence based treatments often provides the best opportunity for long term improvement.

Benefits of Receiving Spravato at Affective Mental Wellness

Choosing where you receive treatment is an important decision.

At Affective Mental Wellness in New Braunfels, Texas, patients receive individualized psychiatric care in a supportive clinical environment.

Services include:

• Psychiatric evaluations

• Medication management

• Spravato treatment

• Telehealth appointments across Texas

The clinic serves patients throughout:

• New Braunfels

• Seguin

• San Marcos

• Canyon Lake

• Schertz

• Bulverde

• Spring Branch

• Garden Ridge

• San Antonio

• Austin

Receiving care close to home can make treatment more convenient, especially because Spravato requires multiple clinic visits.

Frequently Asked Questions

Can anxiety qualify someone for Spravato?

Spravato is not currently approved specifically for anxiety disorders. However, many people with treatment resistant depression also experience anxiety. Your provider will evaluate your complete clinical picture.

Can I continue taking my antidepressant?

Many patients continue taking an oral antidepressant while receiving Spravato. Your provider will discuss your specific treatment plan.

How quickly will I know if Spravato is working?

Every patient responds differently. Some individuals notice improvement sooner than they experienced with traditional antidepressants, while others require additional treatment sessions.

Will insurance cover Spravato?

Coverage varies depending on your insurance plan and medical history. Many insurance providers cover Spravato when medical necessity criteria are met.

Can I drive after treatment?

No. Patients should arrange transportation home because they should not drive after receiving Spravato.

When Should You Talk to a Provider About Spravato?

Consider scheduling an evaluation if:

• Your depression has continued despite multiple medications.

• You feel like you have run out of options.

• Depression is interfering with daily life.

• You continue experiencing symptoms despite ongoing treatment.

• You want to explore advanced treatment options under medical supervision.

A psychiatric evaluation can help determine whether Spravato or another treatment may be appropriate.

The Importance of Individualized Mental Health Care

Depression affects everyone differently.

Some people primarily struggle with sadness, while others experience fatigue, irritability, loss of motivation, changes in sleep, or difficulty concentrating. Because of these differences, treatment should always be personalized.

At Affective Mental Wellness, providers take time to understand your symptoms, medical history, previous treatments, and goals before recommending a plan.

Whether that plan includes Spravato, medication management, IV ketamine therapy, or another approach, the goal is to provide evidence based care tailored to your unique needs.

If you have been asking who qualifies for Spravato treatment, the answer begins with a comprehensive psychiatric evaluation.

Spravato may be an appropriate option for adults with treatment resistant depression who have not experienced enough improvement with traditional antidepressants. Although not every patient will qualify, learning about your options is an important step toward finding the care that best fits your needs.

If you have been living with depression that continues despite treatment, you do not have to navigate it alone.

Schedule a Consultation

If you are interested in learning whether Spravato may be right for you, Affective Mental Wellness is here to help.

Our team provides comprehensive psychiatric evaluations, medication management, Spravato treatment, and telehealth services for patients throughout Texas.

Visit affectivementalwellness.com to schedule your consultation and learn more about your treatment options.